Clinical Trial Update: Atezolizumab and Cabozantinib for the Treatment of Adolescents and Young Adults With Recurrent or Metastatic Osteosarcoma, TACOS Study [Phase 2]

View source ↗

Summary

Phase 2 TACOS trial investigates atezolizumab with cabozantinib for recurrent or metastatic osteosarcoma in adolescents and young adults; recruitment is ongoing…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteosarcoma

Drugs mentioned

• Atezolizumab (atezolizumab)
• cabozantinib (cabozantinib)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Locally Advanced Osteosarcoma, Metastatic Osteosarcoma | Phase 2 | Status: RECRUITING